NM02 Logo.png
Global Surgical Procedures Market to Generate 372,837 thousand units by 2030, Outlines a New Report by Next Move Strategy Consulting
May 20, 2023 00:00 ET | Next Move Strategy Consulting
New York, May 20, 2023 (GLOBE NEWSWIRE) -- According to a new research report by Next Move Strategy Consulting, the Surgical Procedures Market size was 2,94,237 thousand units in 2022, and is...
TeleflexLogo.jpg
New Data Highlight that Early Intervention with the UroLift® System Facilitates Long-Term Outcomes for BPH Patients
May 03, 2023 06:30 ET | Teleflex Incorporated
WAYNE, Pa., May 03, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced new research findings reinforcing the long-term...
Predicine.png
Predicine to Introduce PredicineALERT™ MRD Assay and Present Two ctDNA Studies in Genitourinary Cancers at AUA 2023 Annual Meeting
April 28, 2023 17:42 ET | Predicine
HAYWARD, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- Predicine, a global molecular insights company, announced today that it will present two studies and introduce PredicineALERT™ Minimal Residual...
Blue Water Biotech Appoints Board-Certified Urologist Jay Newmark, M.D., MBA as Chief Medical Officer
April 26, 2023 15:44 ET | Blue Water Biotech, Inc.
CINCINNATI, April 26, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”), a biotechnology company spanning multiple sectors, today announced the appointment of Jay...
FINAL_VeruIncLogo_RGB_300dpi.jpg
Veru Sells ENTADFI® Business for $20 Million Plus up to an Additional $80 Million from Sales Milestones
April 20, 2023 06:45 ET | Veru Inc.
MIAMI, FL, April 20, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for oncology and SARS-CoV-2 and other viral ARDS-related...
NextMed Logo
NextMed Provides Statement Regarding Unaffiliated Entity With Same Name in Wall Street Journal Article
March 29, 2023 06:00 ET | NextMed
TUCSON, Ariz., March 29, 2023 (GLOBE NEWSWIRE) -- Urology and lithotripsy services leader NextMed is issuing this statement in response to an article by the Wall Street Journal, published 4 March...
Iowa Representative Josh Turek - (D)
BetterCaths Coalition Assists Rep. Josh Turek in Designing Better Caths for Iowa Act to Remove Harmful Phthalate Chemical DEHP From Urological Catheters
February 26, 2023 09:31 ET | BetterCaths Health Advocacy Coalition
DES MOINES, Iowa, Feb. 26, 2023 (GLOBE NEWSWIRE) -- In support of the disability community, Iowa State Representative Josh Turek (D-Iowa) has introduced the Better Caths for Iowa Act (H.F. 387) to...
theralase_logo_destroying_cancer.png
Theralase® Phase II NMIBC Clinical Study (Interim) Data Presented at the ASCO GU Cancer Symposium
February 23, 2023 07:00 ET | Theralase Technologies Inc.
TORONTO, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the research...
PVSA
Clinical Research by Anderson Biotests, LLC, in Collaboration With the Bedford Research Foundation, Suggests New Paradigm for Determining Vasectomy Success
February 16, 2023 09:00 ET | Anderson Biotests, LLC
BEDFORD, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Anderson Biotests, LLC, in collaboration with the Bedford Research Foundation (www.bedfordresearch.org), recently published results of analyses of...
UroGPO
Gemini partners with UroGPO, a Specialty Networks Company
January 18, 2023 11:00 ET | Gemini Medical Technologies
Boca Raton, FL, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Gemini Medical Technologies, a privately held U.S.-based urodynamics diagnostics manufacturer, announced a new partnership today with UroGPO, a...